|
Consolidated revenue from operations grew by 44% to Rs 180.8 crore in Q3 FY22 as compared to Rs 125.42 posted in Q3 FY21. Profit before tax increased by 10.3% to Rs 71.5 crore in Q3 FY22 over Q3 FY21.
Total expenses spiked 63.7% to Rs 110.6 crore in Q3 FY22 from Rs 67.6 crore posted in Q3 FY21. The result was announced during market hours today, 7 February 2022.
Shares of Clean Science and Technology were trading 1.5% lower at Rs 2,298 on BSE. Meanwhile, the BSE Sensex was down 1,153 points or 1.97% at 57,491.09.
Clean Science and Technology manufactures functionally critical specialty chemicals such as performance chemicals- mono methyl ether of hydroquinone (MEHQ), butylated hydroxyl anisole (BHA), L-ascorbyl palmitate and anisole.
|